Young Li
Stock Analyst at Jefferies
(0.61)
# 4,154
Out of 5,131 analysts
7
Total ratings
50%
Success rate
-18.3%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Initiates: Buy | $145 | $137.07 | +5.79% | 1 | Oct 13, 2025 | |
| RXST RxSight | Downgrades: Hold | $24 → $9 | $8.84 | +1.81% | 2 | Jul 10, 2025 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $83.45 | +37.81% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.01 | +23.76% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $29.68 | +102.16% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $9.50 | +384.21% | 1 | Jul 16, 2021 |
TransMedics Group
Oct 13, 2025
Initiates: Buy
Price Target: $145
Current: $137.07
Upside: +5.79%
RxSight
Jul 10, 2025
Downgrades: Hold
Price Target: $24 → $9
Current: $8.84
Upside: +1.81%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $83.45
Upside: +37.81%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.01
Upside: +23.76%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $29.68
Upside: +102.16%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $9.50
Upside: +384.21%